1-800-345-8979
Request an Appointment
Find a Center
Contact Us

Samuel C. Kim, M.D.

“I consider it a great blessing to be able to be in a field I’m passionate about, one that translates into having the privilege and responsibility of preserving and restoring a patient’s vision. Being able to provide the highest quality of surgical and clinical care is what I am dedicated to do for all my patients, and as importantly, making them feel confident in me, and comfortable in the approach I’m taking is what I strive for.”

About

Samuel C. Kim, MD is a board-certified retina specialist specializing in vitreoretinal diseases and surgery, including conditions such as diabetic retinopathy, age-related macular degeneration, vascular diseases, uveitis and retinal detachments. Dr. Kim has completed a fellowship in Vitreoretinal diseases and surgical training at the combined Retina Group of Washing/Georgetown University Hospital/Washington Hospital Center, a fellowship known to be one of the top clinical and highest surgical volume programs in the country

Having recently joined the team at Pacific Eye Institute, Dr. Kim is looking forward to providing his patients with the highest quality of surgical and clinical care to patients in the Inland Empire and beyond.

Dr. Kim is an internationally experienced doctor, actively involved in medical missions in Kenya, Zambia and China.

Dr. Kim has been published in multiple journals and has presented at many national meetings including at the annual meetings of American Society of Retinal Specialists. He is actively involved in research and is a Principal Investigator for many national clinical trials through Loma Linda University, including the Diabetic Retinopathy Clinical Research, and is a sub-investigator of numerous other clinical research trials. He serves as an active assistant professor at Loma Linda University and at the Riverside University Health Sciences.

He is an active member of the American Academy of Ophthalmology, the American Society of Retina Specialists and the Christian Ophthalmology Society.

Dr. Kim is fluent in English, Korean, and medical Spanish.

Education & Training

  • College
    Bachelor of Arts, Rhetoric, University of California, Berkeley, California (2001-2005)
    Bachelor of Arts, Molecular and Cell Biology, University of California, Berkeley, California (2001-2005)
  • Medical School
    Doctor of Medicine, Loma Linda School of Medicine
    (2007-2011)
  • Residency
    Loma Linda Eye Institute
    (2012-2015)
  • Fellowship
    Vitreo-Retinal diseases and surgery at the Retina Group of Washington/Georgetown University Hospital/Washington Hospital Center, District of Columbia
    (2015-2017)

Professional Affiliations

  • American Society of Retina Specialists
  • American Academy of Ophthalmology
  • Christian Ophthalmology Society

Publications

  • Principal Investigator: 2018-Present – Sponsored by the Diabetic Retinopathy Clinical Research Network (DRCR.net) and the National Eye Institute (NEI)Study Title: Randomized Clinical Trial Assessing the Effects of Pneumatic Vitreolysis on Vitreomacular Traction (Protocol AG)
  • Principal Investigator: 2018-Present – Sponsored by the Diabetic Retinopathy Clinical Research Network (DRCR.net) and the National Eye Institute (NEI)Study Title: Single-Arm Study Assessing the Effects of Pneumatic Vitreolysis on Macular Hole (Protocol AH)
  • Principal Investigator – May 2018-PresentTitle: Effect of Vegetarian-Diet versus Other Diets on Progression of Non-Exudative Age Related Macular Degeneration: A Retrospective Case-Control study.
  • Principal Investigator – May 2018-PresentTitle: Wet Age-Related Macular Degeneration in Asian Americans and non-Asians: An Analysis of Comparative Outcomes
  • Principal Investigator – May 2018-PresentTitle: Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Diabetic Retinopathy Complicated by Vitreous Hemorrhage
  • Principal Investigator – May 2018-PresentTitle: Efficacy of Intravitreal Bevacizumab in Treatment of Post-Vitrectomy Vitreous Hemorrhage in Patients with Proliferative Diabetic Retinopathy
  • Sub-Investigator – 2017-Present – Sponsored by Quark PharmaceuticalsStudy Title: A phase II/III Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered by Single or Multi-Dose Intravitreal Injection(s) to Subjects with Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
  • Sub-Investigator – 2017-present – Sponsored by AllerganStudy Title: A Phase III, Multicenter, Randomized, Double-Masked, Parallel-Group, Active-Controlled Study of the Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients with Neovascular Age-Related Macular Degeneration (CEDAR)
  • Sub-Investigator – 2017-present – Sponsored by Alcon/NovartisStudy Title: A Two-Year, Phase III, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration (HAWK)
  • Sub-Investigator – March 2018 to July 2018 – Sponsored by NovartisStudy Title: A 24-week, double-masked, multicenter, two-arm extension study to collect safety and efficacy data on brolucizumab 6 mg drug product intended for commercialization in patients with neovascular age-related macular degeneration who have completed the CRTH258A2301 study (HAWK Extension)
  • Sub-Investigator – 2017-Present – Sponsored by the Diabetic Retinopathy Clinical Research Network (DRCR.net) and the National Eye Institute (NEI)Study Title: A phase III, Multicenter, Randomized Clinical Trial of Intravitreous Anti-VEGF Treatment for the Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk (Protocol W)
  • Sub-Investigator – 2017-Present – Sponsored by the Diabetic Retinopathy Clinical Research Network (DRCR.net) and the National Eye Institute (NEI)Study Title: Multicenter, Randomized Clinical Trial of Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy (Protocol AB)
  • Sub-Investigator – 2018-present – Sponsored by the Diabetic Retinopathy Clinical Research Network (DRCR.net) and the National Eye Institute (NEI)Study Title: Genetics in Retinal Diseases Project

Other Studies:

  • West M, Kim S, Khanifar AA. Investigative ophthalmology and visual science. Clinical outcomes in treatment of diabetic macular edema with fluocinolone acetonide intravitreal implant. 58(8):943, 2017.
  • Rodriguez, Kim S, Melamud A. Investigative ophthalmology and visual science. An analysis of visual outcomes in patients with and without postoperative vitreous hemorrhage after diabetic vitrectomy. 58(8):5040, 2017.
  • Kim, SC, Melamud, A. Diabetic Vitreous Hemorrhage. Presented at ARVO 2016. Presented at the annual meeting of American Society of Retinal Surgeons 2017.
  • Kim, SC, Melamud, A. Endophthalmitis Post-Vitrectomy: A Case Control Analysis. Published: Journal of VitreoRetinal Diseases 2018. Presented at American Society of Retinal Surgeons 2016.
  • Kim, SC, Lai, M. Wet Age-Related Macular Degeneration in Asian Americans and non-Asians: An Analysis of Comparative Outcomes. Presented at Retina Society 2016.
  • Kim SC, Fan, J. Two Photon Excited Autofluorescence Imaging of Retina, A Study on Live Rabbit and Rat Eyes. Awarded 1st place at John Affeldt Research Symposium 2014. Presented at Washington Retina Symposium 2015. Presented and published at IVOS
  • Kim SC, Kim D, Ford R, Tokuhara K, The Effect of Caffeine on Microsurgical Performance as Measured by the EYES1 Surgical Stimulator. A double-masked, placebo controlled study to investigate the effects (or lack of effects) of caffeine on surgical performance using the EYESi surgical simulator. Won 1st place at Research Symposium.
  • Sim MW, Elsissy P, Kim SC, Wongworawat M, The Effects of Insurance Type On Delay in Fracture Care. Published in The American Journal of Orthopedics. Awarded 3nd place in San Francisco Resident’s Research Symposium.
  • Kim SC, Narvaez JD, Minimally Invasive Pupillary Cerclage Technique Using Intraocular Forceps. Presented a video at European Society of Cataract and Refractive Surgeons 2011. Presented a video at American Society of Cataract and Refractive Surgeons 2012. Revising a submission to The Journal of Cataract and Refractive Surgery. Awarded 2nd place in John Affeldt Symposium 2013
  • Kim SC, Yashar M, Ortube MC, Gorin M, Nusinowitz S. Detecting Hydroxychloroquine-Related Retinopathy: Sensitivity and Specificity of Clinical Electrophysiological and Psychophysical Tests. Presented poster at Annual Postgraduate Convention 2009, Western Regional Meeting 2009, and UCLA Student Poster Presentation 2008.

Awards & Achievements

  • Assistant Professor, Loma Linda School of Medicine
  • Assistant Professor, Riverside University Health Services
  • Healing Hands Honoree, Loma Linda University
  • Faculty Scholarship, Loma Linda University School of Medicine
  • Chancellor’s Full Academic Scholarship, University of California Berkeley

Common Vision Challenges by Age

20 - 40
Are you tired of glasses & contacts?
Are you curious about LASIK vision correction?

Take Our Free LASIK Self-Evaluation
40 - 50
Has your up-close vision become blurry?
Do you need reading glasses to see menus, text messages, labels, etc.?
50+
Are you experiencing cloudy, yellowed vision?
Have you been diagnosed with cataracts?

Take Our Free Cataract Self-Evaluation